Frontlight ResearchEarly access
Trial site
Messina
- 2running trials
- 3closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease1 trial
- Familial hypercholesterolaemia1 trial
- Hidradenitis suppurativa1 trial
- Metastatic breast cancer1 trial
- Multiple sclerosis1 trial
- Neuroendocrine tumours1 trial
- Stroke1 trial
- Phase
- Phase 32 trials
- Status
- Completed2 trials
- Active, not recruiting1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals5 trials
Running trials
Recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Hidradenitis suppurativa1 recruiting
Closed trials
Completed
Impact of Mayzent on aSPMS Patients in a Long-term NIS in Italy
Completed
Terminated
Site data: ClinicalTrials.govUpdated 17 Nov 2026